Capsule device for delivery of active agent to gastrointestinal tract
US12128201B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2019 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Jul 15, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2210/1042
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral delivery capsule device for delivering an active agent to a part of a gastrointestinal (GI) tract of a subject may include a capsule body configured to travel along the GI tract. The capsule device may include a reservoir configured to contain an active agent for delivery to the GI tract of the subject. The oral delivery capsule device may include an actuation feature configured to provide a delivery force thereby causing the dispensing of the active agent. The oral delivery capsule device may include an actuation control feature configured to prevent actuation of the actuation feature under a first condition and allow actuation under a second condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.